3/13/2012

In an effort to streamline its human pharmaceutical business, Pfizer is divesting its non-core endeavors, including its animal health division. Pfizer will likely spin off the business rather than sell it outright, Pfizer CEO Ian Read said Monday.

Full Story:
Reuters

Related Summaries